The ABCG35 antibody (Catalog: CSB-PA762979XA01DOA) is a rabbit polyclonal antibody developed by CUSABIO Technology LLC. It specifically targets the ABCG35 protein in Arabidopsis thaliana, a model plant organism . ABCG35 belongs to the ATP-binding cassette (ABC) transporter superfamily, which facilitates the transport of sterols, lipids, and other metabolites across cellular membranes .
ABCG35 is part of the ABCG subfamily, which includes proteins critical for sterol homeostasis. In plants, ABCG transporters like ABCG35 mediate the export of secondary metabolites and defense compounds . ABCG35’s homologs in mammals (e.g., ABCG5/ABCG8 heterodimers) are essential for cholesterol excretion, suggesting evolutionary conservation of function .
ELISA: Quantifies ABCG35 levels in plant extracts using recombinant immunogen .
Western Blot: Validates protein expression in Arabidopsis thaliana samples .
Feature | ABCG35 Antibody | ABCG5 Antibody (ab214288) |
---|---|---|
Target Species | Arabidopsis thaliana | Human, Rat |
Applications | ELISA, WB | IHC-P, WB |
Clonality | Polyclonal | Polyclonal |
Key Function | Plant sterol transport | Cholesterol excretion (with ABCG8 partner) |
Storage | -20°C/-80°C | -20°C |
ABCG35 (also known as PDR7 or PLEIOTROPIC DRUG RESISTANCE 7) is an ATP-binding cassette transporter belonging to the G subfamily (ABCG) that plays important roles in plant biology, particularly in Arabidopsis thaliana. It belongs to a class of membrane proteins involved in transport processes related to plant defense mechanisms, hormone transport, and response to environmental stresses. Understanding ABCG35 function provides insights into plant adaptation mechanisms and potential applications in agricultural biotechnology. This protein is identified by several aliases in scientific literature, including ATP-binding cassette G35, ATPDR7, F9L1.15, and F9L1_15 .
Commercial ABCG35 antibodies are typically rabbit polyclonal antibodies that specifically recognize plant antigens, particularly from Arabidopsis thaliana. These antibodies are commonly purified through antigen affinity methods and formulated in preservatives such as Proclin 300 (0.03%) with constituents including glycerol (50%) and PBS (0.01M, pH 7.4). They generally have IgG isotypes and are validated for applications including Western blotting, ELISA, and various immunoassays .
ABCG35 antibodies should be stored at -20°C or -80°C upon receipt to maintain antibody integrity and function. Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and subsequent loss of antibody specificity and activity. For working solutions, aliquoting is recommended to minimize freeze-thaw cycles. Some formulations contain glycerol (50%), which helps maintain stability during freeze-thaw processes .
ABCG35 antibodies have been validated for several key applications in plant research:
Western Blotting: For detecting ABCG35 protein in plant tissue extracts and determining relative expression levels
ELISA (Enzyme-Linked Immunosorbent Assay): For quantitative measurement of ABCG35 in plant samples
Immunoassays: For various detection methods including tissue localization studies
EIA (Enzyme Immunoassay): For sensitive detection in complex biological samples
These applications enable researchers to investigate ABCG35 expression, localization, and potential interactions with other proteins in plant systems.
Antibody concentration optimization is critical for achieving specific signal while minimizing background. Based on studies with other antibodies, titration experiments should be conducted to determine the optimal working concentration:
Begin with a concentration range between 0.1-10 μg/mL, testing multiple dilutions in parallel
Evaluate signal-to-noise ratio at each concentration
Select the lowest concentration that still provides robust and specific detection
Research indicates that antibodies used at concentrations below 0.62 μg/mL often show linear response to dilution, while those used at concentrations above 2.5 μg/mL may show minimal response to titration, suggesting signal saturation . For ABCG35 antibody specifically, starting with concentrations between 0.5-2 μg/mL is recommended for initial optimization experiments.
Proper experimental controls are essential for interpreting results obtained with ABCG35 antibodies:
Positive Control: Use recombinant Arabidopsis thaliana ABCG35 protein supplied with the antibody
Negative Control: Pre-immune serum from the same species as the antibody host (rabbit)
Specificity Controls: Samples from ABCG35 knockout/knockdown plants
Loading Controls: Housekeeping proteins like actin or tubulin for Western blots
Secondary Antibody-Only Control: Omitting primary antibody to assess non-specific binding
Including these controls helps validate antibody specificity and ensures reliable interpretation of experimental results.
Background signal is a common challenge in antibody-based detection methods. For ABCG35 antibodies, several strategies can reduce background:
Optimize antibody concentration - high concentrations (above 2.5 μg/mL) often contribute to increased background signal through non-specific binding
Adjust blocking conditions - use 3-5% BSA or milk proteins in TBS-T with longer blocking times (2+ hours)
Increase washing steps - implement additional and longer wash steps with TBS-T
Reduce staining volume while maintaining antibody concentration
Decrease target cell number during staining to improve signal-to-noise ratio for antibodies targeting abundant epitopes
Research shows that free-floating antibodies in solution significantly contribute to background signal. Analyzing empty droplets versus cell-containing droplets in single-cell applications can help determine the extent of this background contribution .
The interplay between antibody concentration, cell number, and staining volume is critical for optimal ABCG35 detection:
This relationship suggests that optimizing the ratio of antibody molecules to target epitopes is more important than the absolute concentration or volume used.
Validating antibody specificity is crucial for reliable research outcomes. For ABCG35 antibodies, implement these approaches:
Western Blot Analysis: Confirm a single band of expected molecular weight (~165 kDa for ABCG35)
Genetic Controls: Compare wild-type plants with ABCG35 knockout/knockdown lines
Peptide Competition Assay: Pre-incubate antibody with excess immunizing peptide to block specific binding
Orthogonal Detection Methods: Correlate antibody-based detection with mRNA expression data
Cross-Reactivity Testing: Test antibody against related ABC transporters to confirm specificity
These validation steps should be documented in publications to enhance reproducibility and reliability of results.
Poor signal when using ABCG35 antibodies may result from several factors:
Protein Degradation: Ensure proper sample preparation with protease inhibitors
Insufficient Antigen: Increase protein loading or use enrichment methods
Epitope Masking: Try different sample preparation methods or denaturing conditions
Antibody Degradation: Verify antibody quality after storage
Suboptimal Detection Conditions: Adjust incubation times, temperatures, and buffer compositions
Research indicates that antibody signal can be affected by factors beyond concentration, including epitope abundance and accessibility. For antibodies targeting highly abundant epitopes (which may be the case for some plant membrane proteins like ABCG35), reducing cell number during staining can improve signal detection .
ABCG35/PDR7 transporters are implicated in plant stress responses, making their antibodies valuable tools for advanced research applications:
Tissue-Specific Expression Analysis: Track changes in ABCG35 protein levels across different plant tissues under various stress conditions
Subcellular Localization Studies: Use immunofluorescence microscopy to determine if stress alters ABCG35 localization
Co-Immunoprecipitation: Identify stress-induced protein-protein interactions involving ABCG35
Chromatin Immunoprecipitation (ChIP): Study transcriptional regulation of ABCG35 under stress if using antibodies against transcription factors
Comparative Analysis: Examine ABCG35 expression patterns across different plant species to identify conserved stress response mechanisms
These approaches can provide insights into how ABCG35 contributes to plant adaptation mechanisms under environmental stresses.
Mendelian randomization is a powerful approach for establishing causal relationships in biological systems. While typically used in human genetics and epidemiology, similar principles can be applied in plant research using ABCG35 antibodies:
Genetic Instrument Selection: Identify genetic variants affecting ABCG35 expression
Phenotype Association: Measure how these variants correlate with specific plant phenotypes
Antibody-Based Validation: Use ABCG35 antibodies to confirm that genetic variants actually affect protein expression
Pathway Analysis: Combine antibody data with other molecular measurements to map the causal pathway
This methodology, similar to that used in human antibody response studies , allows researchers to establish whether ABCG35 expression directly causes observed phenotypic changes or merely correlates with them.
Time-course experiments are essential for understanding dynamic processes involving ABCG35. Key considerations include:
Temporal Resolution: Determine appropriate sampling intervals based on expected response kinetics
Protein Half-Life: Account for ABCG35 protein turnover rates when interpreting expression changes
Sample Preservation: Implement rapid sampling and preservation methods to capture transient states
Quantitative Analysis: Use standard curves with recombinant ABCG35 protein for absolute quantification
Multi-Parameter Analysis: Correlate ABCG35 protein levels with transcript abundance and functional outcomes
Studies of antibody dynamics in other systems show that temporal patterns provide valuable insights. For example, COVID-19 vaccine research demonstrates that antibody positivity changes over time (28.4% after first dose, increasing to 65.5% after second dose) , highlighting the importance of multiple time points in antibody-related research.
Directed evolution techniques offer powerful methods to enhance antibody properties:
Phage Display Libraries: Generate and screen antibody variants with improved binding to ABCG35
Yeast Surface Display: Evolve antibody fragments with enhanced specificity
Ribosome Display: Select for antibodies with higher affinity in cell-free systems
Computational Design: Use structural prediction to guide mutation sites for improved binding
Stability Engineering: Apply directed evolution to improve antibody resistance to manufacturing stresses
Similar approaches have been successfully used to develop antibodies against other targets, potentially reducing discovery time for improved research reagents . These evolved antibodies could provide enhanced tools for ABCG35 research.
Studies of human antibody responses to pathogens have revealed the existence of multi-donor antibody classes that arise commonly across individuals . Similar principles could be applied to developing antibodies against conserved regions of plant ABC transporters:
Epitope Mapping: Identify conserved regions across ABCG family proteins
Cross-Species Immunization: Immunize with conserved peptides from multiple plant species
Repertoire Analysis: Sequence antibody-producing cells to identify convergent antibody development
Structural Biology: Determine antibody-antigen complex structures to understand binding modes
Rational Design: Engineer antibodies targeting the most conserved epitopes
This approach could yield broadly reactive antibodies capable of recognizing ABCG35 homologs across multiple plant species, enabling comparative studies of ABC transporter function in diverse plant systems.